New guidelines, growth opportunities, and investment in new technologies

Our Press & Policy

Stay up to date with the latest IVD sector news and developments in health policy.

14Jan

Member Press Release – New England Biolabs Multiplex Assay Kit

14 Jan, 2021 | Return|

Member Press Release – New England Biolabs Multiplex Assay Kit

This new research use only kit enables high throughput multiplex detection of SARS-CoV-2 nucleic acid, supports increased sample input and reduces background amplification from possible contaminating genomic DNA.

 

IPSWICH, MA (January 12, 2021) — New England Biolabs® (NEB®) today announced the launch of its Luna® SARS-CoV-2 RT-qPCR Multiplex Assay Kit for real-time detection of SARS-CoV-2 nucleic acid. This research use only (RUO) kit offers multiplex testing of up to 94 samples in a single 96-well plate, with the additional capacity for supporting sample pooling and high throughput applications using 384-well plate test formats.

 

“With the increased demand for high throughput detection of SARS-CoV-2 to advance critical COVID-19 research, there still remains gaps with existing solutions, including the need for updated internal controls and an ability to increase overall assay throughput,” said Steven Chiu, Product Marketing Manager, DNA Amplification, at NEB.

 

Read Full Press Release >  https://www.neb.com/about-neb/news-and-press-releases/new-england-biolabs-expands-its-luna-portfolio-with-the-sars-cov-2-rt-qpcr-multiplex-assay-kit

 

Interested in becoming a member? Join us!

Copyright 2024 BIVDA Ltd is registered in England
Company Number 2687137
Registered Office is 299 Oxford Street (5th floor),
London, W1C 2DZ. VAT Number 563105858